Differentiation and functions of CD8+ effector T cells
https://doi.org/10.22328/2413-5747-2025-11-3-7-15
EDN: VWVQMT
Abstract
OBJECTIVE. Analyze Russian and foreign scientific literature reflecting the mechanisms of CD8+ Т -lymphocyte activation, lysis of infected cells, and the formation of possible immune dysfunctions.
MATERIALS AND METHODS. Recent Russian and international scientific literature from 1998 to 2025 on the biological features of CD8+ Т -lymphocyte activation was studied and analyzed. The primary sources were searched in the RINC, PubMed, Scopus, and Web of Science databases. The following combinations of keywords were used: T-lymphocyte subpopulations, cytotoxic T-lymphocytes, cytokines, granulins, perforin proteins, transcription factors, and hereditary mutations. A total of 49 articles were analyzed.
RESULTS. The differentiation of CD8+ Т cells depends on many factors, including CD4+ T lymphocytes, without which the formation of effector CD8+ T cells and memory T cells does not occur. Interleukins -2, -12, and IFN type I ensure the proliferation of CD8+ Т cells and their differentiation into cytotoxic lymphocytes. They stimulate the expression of transcription factors T-BET and BLIMP-1, which ensure the expression of perforin and granzymes. In chronic viral infections, T-cell differentiation is blocked by programmed cell death protein-1, as well as CTLA-4, TIM-3, LAG-3, and others. KIR receptors transmit inhibitory signals that prevent the destruction of uninfected cells by cytotoxic T lymphocytes. Thanks to the expression of NKG2D receptors, which recognize MHC-like class I molecules—MICA, MICB, and ULBP—that are expressed only by infected or transformed cells, “normal” cells and tissues are not damaged, activating nucleases in target cells. DISCUSSION. Cytotoxic T lymphocytes initiate the destruction of microbial DNA, as well as the genome of the target cell, thereby eliminating potentially infectious DNA. The functioning of cytotoxic T lymphocytes is affected by hereditary mutations associated with perforin and occurring in genes encoding proteins involved in exocytosis.
CONCLUSION. CD8+ Т lymphocytes proliferate and differentiate into CTLs containing cytotoxic granules, which enable them to lyse infected cells. Differentiation into CTLs is accompanied by the acquisition of mechanisms for destroying target cells and controlling various transcription factors. In the case of chronic antigen exposure (tumors, chronic viral infections), CD8+ Т cells initiate a response and begin to express inhibitory receptors that suppress the immune response.
About the Authors
A. V. MoskalevRussian Federation
Alexander V. Moskalev – Dr. of Sci. (Med.), Professor; Professor of the Department of Microbiology
194044, Saint Petersburg, Academician Lebedev Str., 6
V. Ya. Apchel
Russian Federation
Vasily Ya. Apchel – Dr. of Sci. (Med.), Professor; Senior Researcher, Military Medical Academy; Professor of the Department of Anatomy and Physiology of Humans and Animals
194044, Saint Petersburg, Academician Lebedev Str., 6
199155, St. Petersburg, Emb. Moika River, 48, bldg. 3
G. P. Motasov
Russian Federation
Grigory P. Motasov – Dr. of Sci. (Med.), Senior Researcher, Research Institute of Rescue and Underwater Technologies of the Military Training and Scientific Center
198411, Lomonosov, Saint Petersburg, Morskaya Str., 4
References
1. Barkovskaya M. Sh., Blinova E. A., Grishina L. V., Leonova M. I., Nepomnyashchikh V. M., Demina D. V., Kozlov V. A. Content of CD4+ and CD8+ memory effector cells and T-lymphocyte proliferative activity in bronchial asthma. Medical Immunology, 2019, Vol. 21, No. 3, pp. 503–516 (In Russ.).
2. Saydakova E. V., Korolevskaya L. B., Shmagel K. V. Functional state of the pool of regulatory CD4+T-lymphocytes of HIV-infected patients coinfected with hepatitis C virus. Russian Journal of Immunology, 2022, Vol. 25, No. 1, pp. 73–82 (In Russ.).
3. Saidov M. Z. Sterile inflammation, cross-presentation, autophagy and adaptive immunity in immune-inflammatory rheumatic diseases. Medical Immunology, 2024, Vol. 26, No. 3, pp. 465–502 (In Russ.).
4. Sibiryak S. Return to T-suppressors. Medical Bulletin of Bashkortostan, 2007, Vol. 2, No. 3-4, pp. 78–82 (In Russ.).
5. Yatmanov A.N. Improving the system of medical and psychological support for students in universities of the Ministry of Defense of the Russian Federation. Kazan. 2017. 102 p. (In Russ.).
6. Fedulichev P. N. The role of cellular factors in the etiopathogenesis of osteoarthritis. Siberian Scientific Medical Journal, 2023, Vol. 43, No. 2, pp. 61–73 (In Russ.).
7. Zabrovskaya V. G., Kuzmina N. V. Laboratory monitoring of immune system disorders in herpesvirus infection and homeostasis disorders in cardiovascular pathology in residents of Lugansk. Scientific Leader, 2025, No. 22 (223), pp. 70–72 (In Russ.).
8. Artikova S. G. Immunological aspects of the formation of cardiovascular diseases. Economy and Society, 2021, No. 1, Part 1 (80), pp. 374–379 (In Russ.).
9. Ivanov M. F., Balmasova I. P., Malova E. S., Konstantinov D. Yu. Immunopathogenetic features of hemorrhagic fever with renal syndrome as criteria for early immunodiagnostics. Bulletin of the Russian University of Friendship of Peoples. Series: Medicine, 2024, Vol. 28, No. 2, pp. 265–281 (In Russ.).
10. Boeva O. S., Borisevich V. I., Abbasova V. S., Kozlov V. A., Demina D.V., Pashkina E.A. Expression of “non-classical” molecules of the main histocompatibility complex in bronchial asthma and atopic dermatitis. Russian Journal of Immunology, 2025, Vol. 28, No. 2, pp. 229–234 (In Russ.).
11. Illek Ya. Yu., Galanina A. V., Zaitseva G.A., Suslova E.V., Fedyaeva E.A., Mishchenko I.Yu., Leushina N.P., Tarasova E.Yu. Associative connection with antigens of the main histocompatibility complex in atopic dermatitis in children of different ages. Science and the World, 2017, No. 11-2 (51), pp. 47–49 (In Russ.).
12. Moskalev A. V., Gumilevsky B. Yu., Apchel V. Ya., Tsygan V. N. T-lymphocytes as “censor” cells of the immune system. Bulletin of the Russian Military Medical Academy, 2019, No. 2, pp. 191–197 (In Russ.). doi: 10.17816/brmma25943.
13. Moskalev A. V., Gumilevsky B. Yu., Apchel V. Ya., Tsygan V. N. Cellular and humoral factors of innate antiviral immunity. Bulletin of the Russian Military Medical Academy, 2022, No. 4, pp. 751–764 (In Russ.). doi: 10.17816/brmma108136
14. Moskalev A. V., Gumilevsky B. Yu., Apchel V. Ya., Tsygan V. N. Features of the development of adaptive antiviral immune response. Bulletin of the Russian Military Medical Academy, 2022, Vol. 24, No. 4, pp. 789–800 (In Russ.). doi:10.17816/brmma109497.
15. Barber D. L., Wherry E. J., Masopust D., et al. Restoring function in exhausted CD 8 T cells during chronic viral infection. Nature, 2006, Vol. 439, pp. 682–687. doi: 10.1038/nature04444.
16. Blank C. U., Haining W. N., Held W., et al. Defining “T cell exhaustion”. Nat Rev Immunol, 2019, Vol. 19, Р. 665–674. doi: 10.1038/s41577-019-0221-9.
17. Butz E. A., Bevan M. J. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity, 1998, Vol. 8, pp. 167–175. doi: 10.1016/s1074-7613(00)80469-0.
18. Murali-Krishna K., Altman J. D., Suresh M., et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity, 1998, Vol. 8, pp. 177–187. doi: 10.1016/s1074-7613(00)80470-7.
19. Laidlaw B. J., Craft J. E., Kaech S. M. The multifaceted role of CD4+ T cells in CD8+ T cell memory. Nat Rev Immunol, 2016, Vol. 16, pp. 102–111. doi: 10.1038/nri.2015.10.
20. Halle S., Halle O., Forster R. Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo. Trends Immunol, 2017, Vol. 38, pp. 432–443. doi: 10.1016/j.it.2017.04.002.
21. Hashimoto M., Kamphorst A.O., Im S.J., et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev Med, 2018, Vol. 69, pp. 301–318. doi: 10.1146/annurev-med-012017-043208.
22. Henning A. N., Roychoudhuri R., Restifo N. P. Epigenetic control of CD8+ Tcell differentiation. Nat Rev Immunol, 2018, Vol. 18, pp. 340–356. doi: 10.1038/nri.2017.146.
23. McLane L. M., Abdel-Hakeem M. S., Wherry E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol, 2019, Vol. 37, pp. 457–495. doi: 10.1146/annurev-immunol-041015-055318.
24. Tscharke D. C., Croft N. P., Doherty P. C., La Gruta N. L. Sizing up the key determinants of the CD8+ T cell response. Nat Rev Immunol, 2015, Vol. 15, pp. 705–716. doi: 10.1038/nri3905.
25. Zhang N., Bevan M. J. CD8+ T cells: foot soldiers of the immune system. Immunity, 2011, Vol. 35, pp. 161–168. doi: 10.1016/j.immuni.2011.07.010.
26. Voskoboinik I., Whisstock J. C., Trapani J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol, 2015, Vol. 15, pp. 388–400. doi: 10.1016/j.immuni.2011.07.010.
27. Dotiwala F., Lieberman J. Granulysin: killer lymphocyte safeguard against microbes. Curr Opin Immunol, 2019, Vol. 60, pp. 19–29. doi: 10.1016/j.coi.2019.04.013.
28. Golstein P., Griffiths G. M. An early history of T cell-mediated cytotoxicity. Nat Rev Immunol, 2018, Vol. 18, pp. 527–535. doi: 10.1038/s41577-018-0009-3.
29. Ivashkiv L. B. IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol, 2018, Vol. 18, 545–558. doi: 10.1038/s41577-018-0029-z.
30. Dieckmann N. M., Frazer G. L., Asano Y., et al. The cytotoxic T lymphocyte immune synapse at a glance. J Cell Sci, 2016, Vol. 129, pp. 2881–2886. doi: 10.1242/jcs.186205.
31. Schorer M., Kuchroo V. K, Joller N. Role of Co-stimulatory mol ecules in T helper cell differentiation. Adv Exp Med Biol, 2019, Vol. 1189, pp. 153–177. doi: 10.1007/978-981-32-9717-3_6.
32. Mazzoni A., Maggi L., Liotta F., et al. Biological and clini cal significance of T helper 17 cell plasticity. Immunology, 2019, Vol. 158, pp. 287–295. doi: 10.1111/imm.13124.
33. McGeachy M. J., Cua D. J., Gaffen S. L. The IL-17 family of cytokines in health and disease. Immunity, 2019, Vol. 50, pp. 892–906. doi: 10.1016/j.immuni.2019.03.021.
34. Provine N. M., Klenerman P. MAIT cells in health and disease. Annu Rev Immunol, 2020, Vol. 38, pp. 203–228. doi: 10.1146/annurev-immunol-080719-015428.
35. Schmitt N., Ueno H. Regulation of human helper T cell subset differentiation by cytokines. Curr Opin Immunol, 2015, pp. 130–136. 201534. doi: 10.1016/j.coi.2015.03.007.
36. Sungnak W., Wang C., Kuchroo V. K. Multilayer regulation of CD4 T cell subset differentiation in the era of single cell genomics. Adv Immunol, 2019, Vol. 141, pp. 1–31. doi: 10.1016/bs.ai.2018.12.001.
37. Walker J. A., McKenzie A. N. J. TH2 cell development and function. Nat Rev Immunol, 2018, Vol. 18, pp. 121–133. doi: 10.1038/nri.2017.118.
38. Wynn T. A. Type 2 cytokines: mechanisms and therapeutic strat egies. Nat Rev Immunol, 2015, Vol. 15, pp. 271–282. doi: 10.1038/nri3831.
39. Wynn T. A., Chawla A., Pollard J. W. Macrophage biology in development, homeostasis and disease. Nature, 2013, Vol. 496, pp. 445–455. doi: 10.1038/nature12034.
40. Titov L. P., Trusevich M. O. T-cell immunity mechanisms in covid-19: changes in the bone marrow, thymus, lymphocyte subpopulations, function assessment. Healthcare (Minsk), 2024, No. 5 (926), pp. 29–45 (In Russ.).
41. Kasatskaya S. A. T-lymphocytes: travelers and homebodies. Nature, 2016, No. 2 (1206), pp. 8–14 (In Russ.).
42. Yuzhaninova S. V., Saydakova E. V. The phenomenon of immune exhaustion. Advances in Modern Biology, 2017, Vol. 137, No. 1, pp. 70–83 (In Russ.).
43. Stowey R. P., Kozlova E. V., Etman D. L., Welling D. M., Goodwin D. S., Glaser R. Reactivation of chronic herpesvirus infection with age expert commentary on the article “reactivation of chronic herpesvirus infection with age”. Infectious Diseases: News, Opinions, Training, 2013, No. 3 (4), pp. 52–60 (In Russ.).
44. Frolova E. V., Filippova L. V., Uchevatkina A. V., Ponomarenko V. A., Borzova Yu. V., Shurpitskaya O. A., Taraskina A. E., Gaykova L. B., Fedorenko A. S., Gomonova V. V., Latariya E. L., Vasilyeva N. V. Immunological features of patients with covid-19 depending on the severity of the disease. Problems of Medical Mycology, 2021, Vol. 23, No. 1, pp. 3–13 (In Russ.).
45. Ivanova I. A., Filippenko A. V., Pavlovich N. V., Aronova N. V., Tsimbalistova M. V., Anisimova A. S., Omelchenko N. D., Trufanova A. A., Chemisova O. S., Noskov A. K. Immune status of patients with community-acquired pneumonia associated with a new coronavirus infection and other pathogens. Infection and Immunity, 2024, Vol. 14, No. 2, pp. 267–276 (In Russ.).
46. Ivashkin V. T. Mechanisms of immune tolerance and liver pathology. Russian Journal of Gastroenterology, Hepatology, Coloproctology, 2009, Vol. 19, No. 2, pp. 8–13 (In Russ.).
47. Novikov D. K., Velichinskaya O. G., Konevalova O. G. Evaluation of the effectiveness of intradermal autoserohistaminotherapy in patients with autoimmune urticaria. Immunopathology, Allergology, Infectology, 2015, No. 3, pp. 89–98 (In Russ.).
48. Oradovskaya I. V., Radzivil T. T., Vorobyev V. A., Khaitov R. M. Algorithms for changing the immune status of the staff of the Siberian Chemical Combine in the main immunopathological syndromes and immune-dependent diseases. Physiology and Pathology of the Immune System, 2017, Vol. 21, No. 1, pp. 3–32 (In Russ.).
49. Petrovskaya N. N., Pechenikova V. A. Analysis of the features of cellular regulation of immunity in the recurrent course of ovarian endometriosis. Journal of Obstetrics and Women’s Diseases, 2022, Vol. 71, No. 4, pp. 53–63 (In Russ.).
Review
For citations:
Moskalev A.V., Apchel V.Ya., Motasov G.P. Differentiation and functions of CD8+ effector T cells. Marine Medicine. 2025;11(3):7-15. https://doi.org/10.22328/2413-5747-2025-11-3-7-15. EDN: VWVQMT


























